Colorectal Cancer Patient

Immune status at pre-treatment impacts on progression-free survival of metastatic colorectal cancer patients treated with first-line chemotherapy
Kohei Tada, Shigehisa Kitano, Hirokazu Shoji, Takashi Nishimura, Yasuhiro Shimada, Kengo Nagashima, Yoshitaka Honma, Satoru Iwasa, Natsuko Okita, Atsuo Takashima, Ken Kato, Yasuhide Yamada, Naoyuki Katayama, Narikazu Boku, Tetsuya Hamaguchi, Yuji Heike

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P108; DOI: 10.1186/2051-1426-3-S2-P108
Phase I study of alphaviral vector (AVX701) in colorectal cancer patients: comparison of immune responses in stage III and stage IV patients
Michael A Morse, Amy Hobeika, William Gwin, Takuya Osada, Jonathan Gelles, Christel Rushing, Donna Niedzwiecki, H Kim Lyerly

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P444; DOI: 10.1186/2051-1426-3-S2-P444
Immunoscore^® as a predictor of response to chemotherapy in stage II and stage III colon cancer
Bernhard Mlecnik, Anne Berger, Franck Pages, Jerome Galon

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P89; DOI: 10.1186/2051-1426-3-S2-P89
Improved efficacy of radiation in combination with TGFβ inhibition in a colorectal cancer mouse model
Kristina H Young, Benjamin Cottam, Talicia Savage, Jason Baird, David Friedman, Emmanuel Akporiaye, Michael J Gough, Marka Crittenden

Journal for ImmunoTherapy of Cancer Nov 2013, 1 (Suppl 1) P120; DOI: 10.1186/2051-1426-1-S1-P120

Main menu